About this trial
The goal of this prospective observational cohort study is to investigate dressing-related experiences and surgical site self-care in patients who are undergoing a total hip or knee replacement. The main objectives of the study are:
* To evaluate patient adherence to the ISWCAP self-care checklist after total hip or knee replacement within an ERAS pathway. * To explore patient-reported outcomes related to the performance and comfort of advanced dressings. * To assess the perceived adequacy and usefulness of post-discharge wound care education. * To identify the incidence and types of wound-related complications in the 12 weeks following surgery.
Participants will give informed consent before surgery and will start the study once the dressing has been applied following surgery. There will be follow up study visits at discharge, 7 days, 12 days, 6 weeks and 12 weeks post-surgery. Data relating to vital signs, medical history, surgery and medication will be taken from routine data.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults (18+) undergoing primary total hip or knee replacement
Enrolled in an ERAS protocol
Willing and able to provide informed consent
Disqualifiers
Requiring revision replacement
Unable to provide informed consent (cognitive disorder such as dementia, psychiatric illness)
Unable to understand written English
Trial population
Patients undergoing primary total hip or knee replacement at the Nuffield Health Hospital
Trial design
Cohort
Prospective
Treatments tested in this trial
Wound Dressing Material
Other interventionThe study will investigate any wound dressing applied as part of routine care. Advanced wound dressings are highly absorbent, flexible and comfortable for surgical wounds, and offer up to 14 days wear time. The adhesive moulds to the skin without sticking to the wound, thus protecting the skin and wound from damage. They support patient mobilisation by being comfortable, and thereby minimising painful skin damage such as blisters.
Treatment groups
Trial outcomes
Primary outcomes
The proportion of participants responding "yes" to each item of the ISWCAP checklist at 6-weeks post-surgery
Secondary outcomes
Incidence and types of wound complications such as infection, dehiscence (as measured by the Sandy Grading System for surgical wound dehiscence classification), and blistering in the 12-weeks following surgery
Bluebelle Wound Healing Questionnaire, completed at Visits 5 (12-days post-surgery) and 6 (6-weeks post-surgery)
Dressing Comfort and Usability Survey completed at Visits 4 (7-days post-surgery) and 5 (12-days post-surgery)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Bournemouth University
Lead sponsor
Nuffield Health Bournemouth
Collaborator